Why Modify Peptides?
Unmodified peptides have inherent limitations as research tools: short half-lives due to enzymatic degradation, poor membrane permeability, and susceptibility to chemical degradation. Chemical modifications address these limitations while preserving the peptide's biological activity. Understanding common modifications helps researchers interpret COA data, predict stability, and select appropriate compounds for their experiments.
N-Terminal Acetylation (Ac-)
Adding an acetyl group to the N-terminus protects against aminopeptidases — enzymes that degrade peptides from the amino end. Acetylation also neutralizes the positive charge at the N-terminus, which can affect receptor binding and membrane interaction. On a COA, acetylated peptides are designated with Ac- before the sequence.
Effect on molecular weight: adds 42 Da to the expected mass. This should be reflected in mass spectrometry data on the COA.
C-Terminal Amidation (-NH2)
Converting the C-terminal carboxyl group to an amide protects against carboxypeptidases and neutralizes the negative charge at the C-terminus. Many naturally occurring peptide hormones are amidated in vivo. On a COA, amidated peptides show -NH2 after the sequence.
Effect on molecular weight: subtracts 1 Da from the free acid form (replaces -OH with -NH2, net change of -1).
Disulfide Bond Formation
Peptides containing two or more cysteine residues can form intramolecular disulfide bonds, creating cyclic or constrained structures. These bonds significantly improve structural stability and often enhance binding affinity for target receptors. Correct disulfide bond formation is critical and should be verified by mass spectrometry.
PEGylation
Attaching polyethylene glycol (PEG) chains to a peptide increases its molecular size, reducing renal clearance and extending circulation time. PEGylation also shields the peptide from proteolytic enzymes. This modification is primarily relevant to in vivo research contexts.
PEGylated peptides show a broad mass distribution on mass spectrometry due to the polydisperse nature of PEG chains.
Fatty Acid Conjugation
Attaching fatty acid chains (typically palmitic or stearic acid) enables the peptide to bind albumin in biological systems, creating a circulating reservoir that extends duration of action. This approach is used in several GLP-1 receptor agonist compounds to achieve once-weekly research dosing protocols.
D-Amino Acid Substitution
Replacing one or more L-amino acids with their D-amino acid mirror images renders those positions resistant to protease cleavage. Proteases evolved to recognize L-amino acid substrates and cannot efficiently cleave D-amino acid-containing bonds. This modification can dramatically improve in vivo stability without significantly altering receptor binding if the substituted position is not critical for target interaction.
Cyclization
Connecting the N and C termini (head-to-tail cyclization) or side chains creates a ring structure that restricts conformational flexibility. Cyclic peptides are generally more stable, more resistant to proteolysis, and often show improved binding affinity compared to their linear counterparts. The rigidity imposed by cyclization reduces the entropic cost of binding to a structured target.
